Monteleone, Stefania;
Fedorov, Dmitri G;
Townsend-Nicholson, Andrea;
Southey, Michelle;
Bodkin, Michael;
Heifetz, Alexander;
(2022)
Hotspot Identification and Drug Design of Protein–Protein Interaction Modulators Using the Fragment Molecular Orbital Method.
Journal of Chemical Information and Modeling
, 62
(16)
pp. 3784-3799.
10.1021/acs.jcim.2c00457.
Preview |
Text
Townsend-Nicholson_Manuscript_main_revised.R2.pdf Download (1MB) | Preview |
Preview |
Text
Townsend-Nicholson_Manuscript_SI_revised.R2.highlighted.pdf Download (1MB) | Preview |
Abstract
Protein-protein interactions (PPIs) are essential for the function of many proteins. Aberrant PPIs have the potential to lead to disease, making PPIs promising targets for drug discovery. There are over 64,000 PPIs in the human interactome reference database; however, to date, very few PPI modulators have been approved for clinical use. Further development of PPI-specific therapeutics is highly dependent on the availability of structural data and the existence of reliable computational tools to explore the interface between two interacting proteins. The fragment molecular orbital (FMO) quantum mechanics method offers comprehensive and computationally inexpensive means of identifying the strength (in kcal/mol) and the chemical nature (electrostatic or hydrophobic) of the molecular interactions taking place at the protein-protein interface. We have integrated FMO and PPI exploration (FMO-PPI) to identify the residues that are critical for protein-protein binding (hotspots). To validate this approach, we have applied FMO-PPI to a dataset of protein-protein complexes representing several different protein subfamilies and obtained FMO-PPI results that are in agreement with published mutagenesis data. We observed that critical PPIs can be divided into three major categories: interactions between residues of two proteins (intermolecular), interactions between residues within the same protein (intramolecular), and interactions between residues of two proteins that are mediated by water molecules (water bridges). We extended our findings by demonstrating how this information obtained by FMO-PPI can be utilized to support the structure-based drug design of PPI modulators (SBDD-PPI).
Archive Staff Only
 |
View Item |
